The association of genetic variants at PRKAG2 with higher risk for CKD and hypertension as well as lower risk for kidney stone disease suggests a biological link between PRKAG2 and UMOD and suggest that PRKAG2 represents another target to modulate uromodulin-mediated risk of CKD. This evidence concerns the gene PRKAG2 and chronic kidney disease.